Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Viela Bio

Biotech & Life Sciences · Gaithersburg, United States · Founded 2018 · IPO 2019 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$3.05B
Market cap · 2026
Revenue
$12M
Latest reported FY

Investors

9 investors on Viela Bio's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Patent intelligence

$43M patent portfolio · 34 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$43M
1.4% of market cap · 47.5× smaller than top peer Ablynx ($2B)
34 active patent families
Where Viela Bio innovates Molecular biologyAutoimmune diseaseAutoimmune conditionBiochemistryPharmacology
Above peer median on Strategic · Below peer median on Market

Quality vs same-sector peers

Viela Bio on the five Patsnap quality dimensions

Viela Bio in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Viela Bio concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Viela Bio and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Viela Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.